- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/26 - Atomes de soufre
Détention brevets de la classe C07D 295/26
Brevets de cette classe: 369
Historique des publications depuis 10 ans
|
34
|
21
|
24
|
24
|
16
|
23
|
27
|
14
|
16
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20778 |
17 |
| The Scripps Research Institute | 1340 |
16 |
| FUJIFILM Corporation | 30516 |
9 |
| Imago Biosciences, Inc. | 39 |
9 |
| F. Hoffmann-La Roche AG | 7819 |
8 |
| Canopy Growth Corporation | 212 |
8 |
| Cytokinetics, Inc. | 251 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3003 |
7 |
| H. Lundbeck A/S | 1232 |
7 |
| Janssen Pharmaceutica N.V. | 3162 |
6 |
| Board of Regents, The University of Texas System | 6117 |
6 |
| 3m Innovative Properties Company | 17481 |
5 |
| Omeros Corporation | 306 |
5 |
| University of Utah Research Foundation | 1864 |
5 |
| Allergan Sales, LLC | 248 |
4 |
| Axikin Pharmaceuticals, Inc. | 13 |
4 |
| Emory University | 1723 |
4 |
| Novira Therapeutics, Inc. | 32 |
4 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
4 |
| Hoffmann-La Roche Inc. | 3796 |
3 |
| Autres propriétaires | 230 |